Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 02, 2015 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine's DPX-Survivac Induces an Immune Response in Diffuse Large B Cell Lymphoma

HALIFAX, NOVA SCOTIA--(Marketwired - Dec. 2, 2015) - Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that the initial...
July 15, 2015 10:46 ET | Source: Immunovaccine Inc.

Immunovaccine's DPX-Survivac Receives Orphan Drug Designation from the FDA for the Treatment of Ovarian Cancer

HALIFAX, NOVA SCOTIA--(Marketwired - July 15, 2015) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
July 08, 2015 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine and PharmAthene Sign Exclusive Worldwide License Agreement to Develop and Commercialize an Anthrax Vaccine Formulated in DepoVax(TM)

HALIFAX, NOVA SCOTIA--(Marketwired - July 8, 2015) - Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, announced today that it has entered...
July 02, 2015 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Publishes Clinical Results With DPX-Survivac in Combination With an Immune-Modulating Compound

HALIFAX, NOVA SCOTIA--(Marketwired - July 2, 2015) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
June 30, 2015 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Initiates Clinical Trial With DPX-RSV Vaccine

HALIFAX, NOVA SCOTIA--(Marketwired - June 30, 2015) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
June 25, 2015 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Collaborates With Incyte to Evaluate Novel Immunotherapy Combination for Patients With Platinum-Sensitive Ovarian Cancer

HALIFAX, NOVA SCOTIA--(Marketwired - June 25, 2015) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
May 21, 2015 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine to Present at Upcoming Investor Conferences

HALIFAX, NOVA SCOTIA--(Marketwired - May 21, 2015) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
May 12, 2015 17:05 ET | Source: Immunovaccine Inc.

Immunovaccine Announces Financial Results For Quarter Ended March 31, 2015

HALIFAX, NOVA SCOTIA--(Marketwired - May 12, 2015) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
April 27, 2015 07:05 ET | Source: Immunovaccine Inc.

Immunovaccine Joins the OTCQX Marketplace in the United States

HALIFAX, NOVA SCOTIA--(Marketwired - April 27, 2015) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
April 16, 2015 17:05 ET | Source: Immunovaccine Inc.

Immunovaccine Provides Corporate Update and AGM Results

HALIFAX, NOVA SCOTIA--(Marketwired - April 16, 2015) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV) is pleased to provide an update on recent clinical and preclinical...